Swedish Orphan Biovitrum
kr 427.80Change from previous close: −1.52%Absolute change: −kr 6.60
At a glance
- Revenue growth
- +8.50%
- 2025 vs 2024
- Net income growth
- −87.70%
- 2025 vs 2024
- Net margin
- 1.7%
- 2024: 14.9%
Financial data
Amounts in millions of SEK; per-share values in SEK; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | 67,434 | 75,444 | 74,027 | 52,496 | 48,661 |
| Current assets | 14,528 | 13,162 | 12,160 | 11,210 | 8,778 |
| Cash and equivalents | 1,041 | 1,140 | 904 | 1,361 | 1,045 |
| Receivables | 7,930 | 7,381 | 7,062 | 6,140 | 4,105 |
| Inventory | 5,127 | 4,159 | 3,874 | 3,332 | 3,424 |
| Net property, plant and equipment | 1,631 | 1,584 | 1,302 | 274 | 493 |
| Goodwill | 9,024 | 10,456 | 9,642 | 7,007 | 6,288 |
| Other intangible assets | 39,851 | 48,306 | 49,586 | 32,259 | 31,619 |
| Long-term investments | 1,013 | 36.0 | 37.0 | 64.0 | 145 |
| Current liabilities | 16,069 | 12,600 | 19,095 | 14,857 | 8,761 |
| Accounts payable | 1,235 | 944 | 1,024 | 1,252 | 558 |
| Long-term debt | 5,180 | 12,407 | 11,356 | 2,971 | 8,777 |
| Total debt | 11,495 | 16,735 | 20,486 | 9,101 | — |
| Total liabilities | 29,711 | 35,149 | 40,160 | 25,971 | 25,458 |
| Total equity (incl. minority) | 37,723 | 40,295 | 33,867 | 26,525 | 23,203 |
| Retained earnings | 22,402 | 21,924 | 18,055 | 15,793 | 13,155 |
| Minority interest | 6.0 | 9.0 | 0.0 | — | — |